 |
36 Products |  |
29 Diseases | | 36 Products |
|
123 Trials |  |
3033 News |  |
| «12...22232425262728293031323334 |
- ||||| Zepzelca (lurbinectedin) / PharmaMar, Jazz
New P2 trial, BRCA Biomarker, Metastases: A Phase II Clinical Trial of PM01183 in BRCA 1/2-Associated or Unselected Metastatic Breast Cancer (clinicaltrials.gov) - Feb 1, 2012
P2, N=117, Recruiting, Sponsor: PharmaMar
- Zepzelca (lurbinectedin) / PharmaMar, Jazz
New P2 trial, Metastases: Study of PM01183 in platinum-resistant / refractory advanced ovarian cancer patients. Estudio de PM01183 en pacientes con c (EUDRACT) - Aug 8, 2011
P2, N=39, Ongoing, Sponsor: Pharma Mar S.A. Sociedad Unipersonal